Humanigen, Inc., a clinical stage biopharmaceutical company focused on preventing and treating cytokine release syndrome with lenzilumab, the company’s proprietary Humaneered® anti-human granulocyte macrophage-colony stimulating factor monoclonal antibody, announced that the first patient has been infused in the ZUMA-19 study, which is being conducted in collaboration with Kite, A Gilead Company.

Go to Source

Start Free Trial: Database Active Pharma Ingredients Manufacturers

– API Database contains 43 000 generic API listed with price ranges. Including regulatory information, price ranges US market, EU, Canada, and other regulated markets and rest of the world.

– A list of more than 5000 verified API vendors.
including DMF’s availability, Purity, CEP, FDF dossier availability, contact details/ Distributors/branch, etc.

– A list of Pharmaceutical Excipients Vendors
including regulatory information, price ranges, contact details, etc.

– Pharmaceutical dossiers for sale and Impurity Standards. List of owners and contact details.

You can cancel your subscription anytime.